CYT · Categories · Form 4

CYT - SEC Form 4 insider transactions

Cyteir Therapeutics Inc. (CYT) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for CYT

• 782d
  Gaiero David G exercised 10,358 shares at a strike of $1.69, increasing direct ownership by 11% to 102,391 units (SEC Form 4)

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 782d
  Renschler Markus Md exercised 21,448 shares at a strike of $1.63, increasing direct ownership by 2% to 1,103,661 units (SEC Form 4)

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 800d
  George Jean exercised 14,150 shares at a strike of $1.69 (SEC Form 4)

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 802d
  Sands Stephen H. exercised 12,129 shares at a strike of $1.69 (SEC Form 4)

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 804d
  Thero John F exercised 12,828 shares at a strike of $1.69, increasing direct ownership by 128% to 22,828 units (SEC Form 4)

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 808d
  Zakrzewski Joseph S exercised 14,150 shares at a strike of $1.69, increasing direct ownership by 7% to 227,439 units (SEC Form 4)

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 864d
  Gaiero David G exercised 3,993 shares at a strike of $1.69, increasing direct ownership by 5% to 92,033 units (SEC Form 4)

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 864d
  Renschler Markus Md exercised 8,840 shares at a strike of $1.55, increasing direct ownership by 0.82% to 1,082,213 units (SEC Form 4)

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 886d
  Renschler Markus Md exercised 84,637 shares at a strike of $1.53, increasing direct ownership by 9% to 1,073,373 units (SEC Form 4)

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 886d
  Gaiero David G exercised 73,940 shares at a strike of $1.68, increasing direct ownership by 524% to 88,040 units (SEC Form 4)

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1011d
  SEC Form 4 filed by Novo Holdings A/S

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1013d
  SEC Form 4 filed by Novo Holdings A/S

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1028d
  SEC Form 4 filed by Novo Holdings A/S

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1033d
  SEC Form 4 filed by Novo Holdings A/S

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1038d
  SEC Form 4 filed by Novo Holdings A/S

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1041d
  SEC Form 4 filed by Novo Holdings A/S

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1047d
  SEC Form 4 filed by Novo Holdings A/S

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1174d
  SEC Form 4 filed by Zakrzewski Joseph S

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1174d
  SEC Form 4 filed by Thero John F

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1174d
  SEC Form 4 filed by Sands Stephen H.

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1174d
  SEC Form 4 filed by Romberger Timothy

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1174d
  SEC Form 4 filed by Molineaux Susan

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1174d
  SEC Form 4 filed by Humphrey Jeffrey

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1174d
  SEC Form 4 filed by George Jean

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1174d
  SEC Form 4 filed by Bracken Racquel

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1174d
  SEC Form 4: Gaiero David G was granted 5,000 shares, increasing direct ownership by 122% to 9,100 units

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1174d
  SEC Form 4: Gaiero David G exercised 4,100 shares at a strike of $1.68

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1174d
  SEC Form 4 filed by Veness Adam M

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1174d
  SEC Form 4: Renschler Markus Md was granted 5,000 shares, increasing direct ownership by 0.51% to 983,736 units

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1220d
  SEC Form 4: Renschler Markus Md exercised 136,782 shares at a strike of $1.07, increasing direct ownership by 16% to 978,736 units

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1235d
  SEC Form 4 filed by Zakrzewski Joseph S (Amendment)

  4/A - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1235d
  SEC Form 4: Zakrzewski Joseph S bought $27,563 worth of shares (21,202 units at $1.30), increasing direct ownership by 16% to 154,618 units

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1374d
  SEC Form 4: Novo Holdings A/S sold $2,700,000 worth of shares (900,000 units at $3.00), decreasing direct ownership by 19% to 3,940,413 units

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1441d
  SEC Form 4: Zakrzewski Joseph S bought $1,196 worth of shares (743 units at $1.61), increasing direct ownership by 0.56% to 133,416 units

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1445d
  SEC Form 4: Thero John F bought $20,000 worth of shares (10,000 units at $2.00)

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1445d
  SEC Form 4: Zakrzewski Joseph S bought $95,077 worth of shares (50,406 units at $1.89), increasing direct ownership by 61% to 132,673 units

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1453d
  SEC Form 4 filed by Veness Adam M

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1522d
  SEC Form 4 filed by Molineaux Susan

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1522d
  SEC Form 4 filed by Zakrzewski Joseph S

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1522d
  SEC Form 4 filed by Renschler Markus Md

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1522d
  SEC Form 4 filed by Humphrey Jeffrey

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1522d
  SEC Form 4 filed by Bracken Racquel

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1522d
  SEC Form 4 filed by George Jean

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1522d
  SEC Form 4 filed by Romberger Timothy

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1522d
  SEC Form 4 filed by Gengos Andrew

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1522d
  SEC Form 4 filed by Naesens Janwillem

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1522d
  SEC Form 4 filed by Secrist John Paul

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1522d
  SEC Form 4 filed by Gaiero David G

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1522d
  SEC Form 4 filed by Sands Stephen H.

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1539d
  SEC Form 4 filed by Thero John F

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1580d
  SEC Form 4: Zakrzewski Joseph S bought $10,896 worth of shares (1,100 units at $9.91), increasing direct ownership by 1% to 82,267 units

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1587d
  SEC Form 4: Zakrzewski Joseph S bought $1,976 worth of shares (200 units at $9.88), increasing direct ownership by 0.25% to 81,167 units

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1592d
  SEC Form 4 filed by Humphrey Jeffrey

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)
• 1593d
  SEC Form 4: Zakrzewski Joseph S bought $39,844 worth of shares (3,700 units at $10.77), increasing direct ownership by 5% to 80,967 units

  4 - Cyteir Therapeutics, Inc. (0001662244) (Issuer)

Other CYT categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends